HIV-1 integrase resistance associated mutations and the use of dolutegravir in Sub-Saharan Africa: A systematic review and meta-analysis

As sub-Saharan Africa (SSA) countries are transitioning to dolutegravir (DTG)-based ART, baseline data are required for optimal monitoring of therapeutic response. In this frame, we sought to generate up-to-date evidence on the use of integrase-strand transfer inhibitors (INSTI) and associated drug...

Whakaahuatanga katoa

I tiakina i:

Ngā taipitopito rārangi puna kōrero
Ngā kaituhi matua:	Ezechiel Ngoufack Jagni Semengue, Maria Mercedes Santoro, Valantine Ngum Ndze, Aude Christelle Ka’e, Bouba Yagai, Alex Durand Nka, Beatrice Dambaya, Desiré Takou, Georges Teto, Lavinia Fabeni, Vittorio Colizzi, Carlo-Federico Perno, Francesca Ceccherini-Silberstein, Joseph Fokam
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	Public Library of Science (PLoS) 2022-01-01
Rangatū:	PLOS Global Public Health
Urunga tuihono:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10021461/?tool=EBI
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!

HIV-1 integrase resistance associated mutations and the use of dolutegravir in Sub-Saharan Africa: A systematic review and meta-analysis

Ngā tūemi rite